Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases.
Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our...
Biotechnology Research,Drug Manufacturing & Research,Biotechnology,Oncology drug discovery,Pharmaceuticals,Science and Engineering,Oncology,Healthcare,Health Care,Genomically defined diseases,Medical,Rare diseases,Transformative drugs,Robust drug pipeline,Systemic mastocytosis,Hepatocellular carcinoma,Orphan drugs,Small molecules,Kinase inhibitor,Personalized medicine,Novel cancer therapies